Why CRISPR babies are still too risky — embryo studies highlight challenges
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 615, 568-569 (2023)
Alanis-Lobato, G. et al. Proc. Natl Acad. Sci. USA 118, e2004832117 (2021).
Liang, D. et al. Nature Commun. 14, 1219 (2023).
Kang, Y. et al. Sci. Adv. 8, eabo3123 (2022).